I.M. Nilsson

446 total citations
20 papers, 367 citations indexed

About

I.M. Nilsson is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, I.M. Nilsson has authored 20 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in I.M. Nilsson's work include Estrogen and related hormone effects (4 papers), Platelet Disorders and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). I.M. Nilsson is often cited by papers focused on Estrogen and related hormone effects (4 papers), Platelet Disorders and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). I.M. Nilsson collaborates with scholars based in Sweden, Finland and United Kingdom. I.M. Nilsson's co-authors include Birger Åstedt, Lars Holmberg, Gösta Rooth, L Svanberg, Hans Modig, Gunnar Westman, Mikael Donnér, S Borgström, Maurizio Pandolfi and Jouni Vuorinen and has published in prestigious journals such as The Lancet, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

I.M. Nilsson

20 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I.M. Nilsson Sweden 11 122 119 99 93 58 20 367
Joseph Corkery United States 8 33 0.3× 73 0.6× 51 0.5× 74 0.8× 91 1.6× 8 331
R. Sartorio Italy 9 95 0.8× 201 1.7× 235 2.4× 48 0.5× 152 2.6× 13 619
Fletcher Ap United States 10 39 0.3× 131 1.1× 82 0.8× 36 0.4× 54 0.9× 16 414
Fulvio Brema Italy 12 78 0.6× 86 0.7× 136 1.4× 388 4.2× 79 1.4× 36 562
Judith Leurs Belgium 11 42 0.3× 274 2.3× 84 0.8× 42 0.5× 102 1.8× 12 400
Mustafa Yaylacı Türkiye 10 47 0.4× 45 0.4× 47 0.5× 187 2.0× 49 0.8× 28 413
Desmond Robb Canada 7 65 0.5× 43 0.4× 36 0.4× 141 1.5× 91 1.6× 9 328
Halil Gürhan Karabulut Türkiye 11 46 0.4× 85 0.7× 34 0.3× 28 0.3× 130 2.2× 42 369
Ronald K. Knickerbocker United States 8 181 1.5× 134 1.1× 17 0.2× 181 1.9× 127 2.2× 10 556
Vincenzo Toscano Italy 8 94 0.8× 40 0.3× 66 0.7× 33 0.4× 193 3.3× 18 357

Countries citing papers authored by I.M. Nilsson

Since Specialization
Citations

This map shows the geographic impact of I.M. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. Nilsson more than expected).

Fields of papers citing papers by I.M. Nilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.M. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. Nilsson. The network helps show where I.M. Nilsson may publish in the future.

Co-authorship network of co-authors of I.M. Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of I.M. Nilsson. A scholar is included among the top collaborators of I.M. Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.M. Nilsson. I.M. Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monstein, Hans‐Jürg, et al.. (1998). Cloning and characterization of 5'-end alternatively spliced human cholecystokinin-B receptor mRNAs.. PubMed. 6(3). 165–77. 10 indexed citations
2.
Pyrhönen, Seppo, Ritva Valavaara, Hans Modig, et al.. (1997). Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. British Journal of Cancer. 76(2). 270–277. 80 indexed citations
3.
Donnér, Mikael, Erik Berntorp, E. Scheibel, et al.. (1993). Two new candidate mutations in type IIA von Willebrand's disease (ARG834→GLY, GLY846→ARG) and one polymorphism (TYR821→CYS) in the A2 region of the von Willebrand factor. European Journal Of Haematology. 51(1). 38–44. 10 indexed citations
4.
Jönsson, P.-E., et al.. (1991). Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.. PubMed. 11(2). 873–5. 18 indexed citations
6.
Modig, Hans, S Borgström, I.M. Nilsson, & Gunnar Westman. (1990). Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication. Journal of Steroid Biochemistry. 36(3). 235–236. 16 indexed citations
7.
Modig, Hans, S Borgström, I.M. Nilsson, & Gunnar Westman. (1990). Phase II clinical study of high-dose toremifene in patients with advanced breast cancer. Journal of Steroid Biochemistry. 36(3). 237–238. 9 indexed citations
8.
Nilsson, I.M., et al.. (1989). Radical Radiotherapy in Prostatic Carcinoma. Acta Oncologica. 28(2). 261–266. 2 indexed citations
9.
Lecander, Ingegerd, I.M. Nilsson, & Birger Åstedt. (1988). Depression of plasminogen activator activity during pregnancy by the placental inhibitor PAI 2. Fibrinolysis and Proteolysis. 2(3). 165–167. 15 indexed citations
10.
Donnér, Mikael, Lars Holmberg, & I.M. Nilsson. (1987). Type IIB von Willebrand's disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. British Journal of Haematology. 66(3). 349–354. 23 indexed citations
11.
Nilsson, I.M.. (1985). Two different mechanisms in patients with venous thrombosis and defective fibrinolysis. BMJ. 290(6484). 1826.3–1826. 4 indexed citations
12.
Holmberg, Lars, I.M. Nilsson, P. Henriksson, & Karen Helene Ørstavik. (1978). Homozygous Expression of Haemophilia B in a Heterozygote. Acta Medica Scandinavica. 204(1-6). 231–234. 9 indexed citations
13.
Nilsson, I.M., et al.. (1977). Plasminogen Activator Release After Venous Occlusion and Infusion of DDAVP. Thrombosis and Haemostasis. 3 indexed citations
14.
Holmberg, Lars & I.M. Nilsson. (1975). Von Willebrand's Disease. Annual Review of Medicine. 26(1). 33–44. 25 indexed citations
15.
Nilsson, I.M., et al.. (1974). FIBRINOLYTIC ACTIVITY AND TREATMENT OF DIABETES. The Lancet. 303(7870). 1342–1342. 14 indexed citations
16.
Pandolfi, Maurizio & I.M. Nilsson. (1972). On Coagulation and Fibrinolysis in Trauma and Shock. European Surgical Research. 4(3). 153–165. 5 indexed citations
17.
Nilsson, I.M. & Birger Åstedt. (1971). Blood clotting and contraception.. BMJ. 2(5761). 589.3–590. 7 indexed citations
18.
Björlin, G, Maurizio Pandolfi, & I.M. Nilsson. (1971). Fibrinolytic activity in odontogenic cysts. Oral Surgery Oral Medicine Oral Pathology. 32(3). 424–427. 11 indexed citations
19.
Åstedt, Birger, L Svanberg, & I.M. Nilsson. (1971). Fibrin Degradation Products and Ovarian Tumours. BMJ. 4(5785). 458–459. 46 indexed citations
20.
Rooth, Gösta & I.M. Nilsson. (1964). STUDIES ON FOETAL AND MATERNAL METABOLIC ACIDOSIS.. PubMed. 26. 121–32. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026